Zobrazeno 1 - 10
of 25
pro vyhledávání: '"Yuto, Takebayashi"'
Autor:
Tohru Ohnuma, Tohru Nakamura, Yuto Takebayashi, Ryo Hanzawa, Maiko Kitazawa, Ryoko Higashiyama, Mayu Takeda, Katrin Thompson, Miwa Komatsu, Hiromi Shimazaki, Nobuto Shibata, Heii Arai
Publikováno v:
Dementia and Geriatric Cognitive Disorders Extra, Vol 2, Iss 1, Pp 496-502 (2012)
Background/Aims: PiggyBac transposable element derived 1 (PGBD1) encodes a molecule involved in epigenetic mechanisms that have been implicated in Alzheimer’s disease (AD), and recent genome-wide association studies and meta-analyses have indicated
Externí odkaz:
https://doaj.org/article/8703d06e5ac0484191a653f5cbd09579
Autor:
Mariko Nakadaira, Tohru Ohnuma, Hiroki Yamashita, Ken Nakayama, Yasue Miki, Narimasa Katsuta, Hitoki Hirose, Narihiro Orimo, Heii Arai, Wanyi Mao, Yuto Takebayashi, Eriko Tani, Shohei Nishimon
Publikováno v:
Juntendo Medical Journal. 65:268-278
Autor:
Tomohito Gohda, Ayako Kimoto, Mayu Takeda, Yusuke Suzuki, Narimasa Katsuta, Eriko Tani, Heii Arai, Yuto Takebayashi, Nobuto Shibata, Shohei Nishimon, Ryoko Higashiyama, Toru Nakamura, Yasuhiko Tomino, Yasue Miki, Sho-ichi Yamagishi, Tohru Ohnuma, Takahiro Sannohe, Masayoshi Takeuchi
Publikováno v:
Progress in Neuro-Psychopharmacology and Biological Psychiatry. 76:42-48
Background Carbonyl stress in patients with schizophrenia has been reported to be reflected by an increase in peripheral pentosidine levels. This cohort study tested whether the accumulation of pentosidine was related to the disease severity or the t
Autor:
Toshiaki Onitsuka, Takefumi Ueno, Kiyoto Kasai, Hironori Kuga, Masaki Fukunaga, Chika Sumiyoshi, Tomiki Sumiyoshi, Yuka Yasuda, Yuto Takebayashi, Yuko Okahisa, Kazuto Oya, Manabu Takaki, Norio Ozaki, Atsuhito Toyomaki, Michiko Fujimoto, Masanori Isobe, Ryota Hashimoto, for Cocoro, Kenichiro Miura, Naohiro Okada, Naoko Kawano, Shuichi Isomura, Naoki Hashimoto, Tohru Ohnuma, Masaki Kato, Haruo Fujino, Osamu Imura, Hidenaga Yamamori
Publikováno v:
Psychiatry and Clinical Neurosciences. 71:294-300
Aim Studies have reported that cognitive decline occurs after the onset of schizophrenia despite heterogeneity in cognitive function among patients. The aim of this study was to investigate the degree of estimated cognitive decline in patients with s
Autor:
Nobuto Shibata, Narimasa Katsuta, Yusuke Suzuki, Hitoshi Maeshima, Yasuhiko Tomino, Heii Arai, Ryoko Higashiyama, Tomohito Gohda, Motoyuki Higa, Shohei Nishimon, Toru Nakamura, Mayu Takeda, Yuri Hotta, Sho-ichi Yamagishi, Ryo Hanzawa, Yuto Takebayashi, Takahiro Sannohe, Masayoshi Takeuchi, Tohru Ohnuma
Publikováno v:
Neuroscience Letters. 593:51-55
Recent cross-sectional and longitudinal studies indicate that measurements of peripheral blood carbonyl stress markers such as the advanced glycation end product (AGE) pentosidine and the reactive carbonyl-detoxifying B6 vitamin pyridoxal could be us
Autor:
Mayu Takeda, Narimasa Katsuta, Ryo Hanzawa, Nobuto Shibata, Yuri Hotta, Heii Arai, Shohei Nishimon, Ryoko Higashiyama, Toru Nakamura, Hitoshi Maeshima, Tohru Ohnuma, Takahiro Sannohe, Motoyuki Higa, Yuto Takebayashi
Publikováno v:
Schizophrenia Bulletin. 40:1366-1373
Altered peripheral carbonyl stress markers, high levels of serum pentosidine, which accumulates following carbonyl stress, and low levels of pyridoxal (vitamin B6), which detoxifies reactive carbonyl compounds, have been reported in a cross-sectional
Autor:
Hiroki Yamashita, Hitoki Hirose, Wanyi Mao, Yasushi Suga, Eriko Tani, Ken Nakayama, Shigaku Ikeda, Etsuko Komiyama, Yasue Miki, Toshio Hasegawa, Shohei Nishimon, Mariko Nakadaira, Yuto Takebayashi, Narimasa Katsuta, Narihiro Orimo, Tohru Ohnuma, Heii Arai
Publikováno v:
International Journal of Methods in Psychiatric Research. 28:e1769
Objectives Photosensitivity to ultraviolet A (UVA) radiation from sunlight is an important side effect of treatment with antipsychotic agents. However, the pathophysiology of drug-induced photosensitivity remains unclear. Recent studies demonstrated
Publikováno v:
Asia-Pacific Psychiatry. 5:336-343
Introduction Treatment-resistant schizophrenia (TRS) refers to the approximately 20–30% of schizophrenia patients whose symptoms are resistant to any antipsychotic treatment. For the improvement of residual symptoms in TRS, augmentation therapy usi
Autor:
Yasuhiko Tomino, Ryoko Higashiyama, Shohei Nishimon, Nobuto Shibata, Takahiro Sannohe, Tohru Ohnuma, Mayu Takeda, Narimasa Katsuta, Toru Nakamura, Yusuke Suzuki, Tomohito Gohda, Ayako Kimoto, Heii Arai, Yuto Takebayashi, Sho-ichi Yamagishi
Publikováno v:
Progress in neuro-psychopharmacologybiological psychiatry. 76
Inflammation may be involved in the pathophysiology of schizophrenia. However, few cross-sectional or longitudinal studies have examined changes in biomarker expression to evaluate diagnostic and prognostic efficacy in acute-stage schizophrenia. We c
Autor:
Ayako, Kimoto, Tohru, Ohnuma, Aiko, Toda, Yuto, Takebayashi, Ryoko, Higashiyama, Yuko, Tagata, Masanobu, Ito, Tsuneyoshi, Ota, Nobuto, Shibata, Heii, Arai
Publikováno v:
Psychogeriatrics : the official journal of the Japanese Psychogeriatric Society. 17(6)